Congressional Staffing Intelligence

Hillgraph
Menu
BillsHH.R. 8205

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

119th CongressIntroduced April 6, 2026Rep. Quigley, Mike [D-IL-5]· IL-05
Stage
In other chamber
Latest action
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 466.
July 23, 2026

Summary

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 This bill reauthorizes through FY2031 and revises programs that support research and development of drugs and other

Committees

  • PrimaryEnergy and Commerce Committee

CRS subjects

Department of Health and Human ServicesDrug therapyFood and Drug Administration (FDA)

Action history

  1. April 6, 2026Introduced in House
  2. April 6, 2026Introduced in House
  3. April 6, 2026Referred to the House Committee on Energy and Commerce.
  4. April 6, 2026Referred to the Subcommittee on Health.
  5. May 13, 2026Subcommittee Consideration and Mark-up Session Held
  6. May 13, 2026Forwarded by Subcommittee to Full Committee by Voice Vote.
  7. May 21, 2026Committee Consideration and Mark-up Session Held
  8. May 21, 2026Ordered to be Reported (Amended) by the Yeas and Nays: 46 - 0.
  9. July 9, 2026Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-733.
  10. July 9, 2026Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-733.
  11. July 9, 2026Placed on the Union Calendar, Calendar No. 637.
  12. July 20, 2026Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
  13. July 20, 2026Considered under suspension of the rules. (consideration: CR H4652-4654; text: CR H4653)
  14. July 20, 2026DEBATE - The House proceeded with forty minutes of debate on H.R. 8205.
  15. July 20, 2026At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Guthrie objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was considered as withdrawn.
  16. July 22, 2026Considered as unfinished business. (consideration: CR H5159)
  17. July 22, 2026Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
  18. July 22, 2026On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
  19. July 22, 2026Motion to reconsider laid on the table Agreed to without objection.
  20. July 23, 2026Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 466.

Cosponsors (100)

Text versions

Related bills

  • S. 4472related
    Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026